Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis

INTRODUCTION: The European Medicines Agency has suspended the use of ulipristal acetate (UPA) in the treatment of uterine fibroids and is reassessing its association with a risk of liver injury. OBJECTIVES: Our objectives were to characterize the post-marketing reporting of drug-induced liver injury...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatti, Milo, Poluzzi, Elisabetta, De Ponti, Fabrizio, Raschi, Emanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686198/
https://www.ncbi.nlm.nih.gov/pubmed/32748236
http://dx.doi.org/10.1007/s40264-020-00975-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686198/
https://www.ncbi.nlm.nih.gov/pubmed/32748236
http://dx.doi.org/10.1007/s40264-020-00975-8

Ejemplares similares